Dr. Krogan was born and raised in Regina, Saskatchewan, Canada and obtained his undergraduate degree from the University of Regina and his Ph.D. in Medical Genetics from the University of Toronto, Canada. As a graduate student, he pioneered the systematic affinity tagging, purification and analysis of the majority of proteins in yeast, leading to the most comprehensive protein-protein interaction map of any organism at the time. He is a professor of Cellular and Molecular Pharmacology at the University of San Francisco, where his lab focuses on unbiased proteomic and genomic studies of cellular interactions involved in infectious disease, neuropsychiatric disorders and cancer. He is also a Senior Investigator at the J. David Gladstone Institutes and Director of the California Institute for Quantitative Biosciences ([email protected]) and Director of the Quantitative Biosciences Institute, as well as the Director of the Thermo Fisher Scientific Proteomics Facility for Disease Target Discovery. He is a former Sandler Fellow at UCSF, a Searle Scholar and Keck Young Investigator and was named to the “40 Under 40” list by Cell and has won numerous awards, including the Roddenberry Prize.
3 Medical Innovations Fueled By COVID-19 That Will Outlast The Pandemic
A number of technologies and tools got a chance to prove themselves for the first time in the…